ReviewCardiovascular diabetology2018

Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell chemokines.

Milton PackerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.